Company news

Brii Biosciences Limited news in 2025

Brii Biosciences Limited's news releases, calls and decks from 2025, newest first.

View company

Brii Biosciences and OpenBench Announce AI-Driven Collaboration for Proprietary Technology Platform

December 11, 2025

Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B

November 10, 2025

Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine

November 7, 2025

Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results

August 21, 2025

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

July 3, 2025

Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss

May 7, 2025

Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification

March 30, 2025

Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results

March 21, 2025

Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study

January 2, 2025

Decks in 2025